Based on the Hepion Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Hepion Pharmaceuticals Inc is not available over the next 12 months. Hepion Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Hepion Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Hepion Pharmaceuticals Inc’s stock price was USD 0.02. Hepion Pharmaceuticals Inc’s stock price has changed by -71.23% over the past week, -88.64% over the past month and -99.05% over the last year.
No recent analyst target price found for Hepion Pharmaceuticals Inc
No recent average analyst rating found for Hepion Pharmaceuticals Inc
Company Overview Hepion Pharmaceuticals Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Hepion Pharmaceuticals Inc (HEPA)
Loading...
Unadjusted Closing Price for Hepion Pharmaceuticals Inc (HEPA)
Loading...
Share Trading Volume for Hepion Pharmaceuticals Inc Shares
Loading...
Compare Performance of Hepion Pharmaceuticals Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for HEPA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Hepion Pharmaceuticals Inc (Sector: Biotechnology )
Frequently Asked Questions About Hepion Pharmaceuticals Inc (HEPA) Stock
Stock Target Advisor's fundamental analysis for Hepion Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on HEPA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on HEPA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on HEPA's stock to indicate if its overvalued.
The last closing price of HEPA's stock was USD 0.02.
Unfortunately we do not currently have any market capitalization data for HEPA's stock.
Unfortunately we do not have enough analyst data on HEPA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Hepion Pharmaceuticals Inc's stock.
Sorry, we do not have any data on the number of employees for Hepion Pharmaceuticals Inc.
Sorry we do not have any infomation available on Hepion Pharmaceuticals Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Hepion Pharmaceuticals Inc (HEPA) Stock
Stock Target Advisor's fundamental analysis for Hepion Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on HEPA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on HEPA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on HEPA's stock to indicate if its overvalued.
The last closing price of HEPA's stock was USD 0.02.
Unfortunately we do not currently have any market capitalization data for HEPA's stock.
Unfortunately we do not have enough analyst data on HEPA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Hepion Pharmaceuticals Inc's stock.
Sorry, we do not have any data on the number of employees for Hepion Pharmaceuticals Inc.
Sorry we do not have any infomation available on Hepion Pharmaceuticals Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HEPA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
